Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07556367 · ClinicalTrials.gov registry record · NA
Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients
A NA study, sponsored by University of California, San Francisco.
- Active
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT07556367: Active NA study, sponsored by University of California, San Francisco.
NCT07556367 is a NA study that is active but no longer recruiting, run by University of California, San Francisco. The registered enrollment target is 43 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07556367, a NA study, is active but no longer recruiting, sponsored by University of California, San Francisco.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
This is a pilot study evaluates the feasibility and outcomes of providing fluoride varnish treatment during routine cancer surveillance visits for post-radiation head and neck cancer patients with limited access to dental care.
Primary Outcome
The Feasibility of Intervention Measure (FIM) is a 4-item implementation measure that assesses participants or providers' perceived feasibility of the intervention. Responses are rated on a 5-point Likert scale ranging from 1 (Completely Disagree) to 5 (Completely Agree). The survey is administered at baseline and at each surveillance visit.
Interventions
- OTHER Surveys
- PROCEDURE Saliva Collection
- PROCEDURE Intra-oral photographs
- DEVICE Fluoride Varnish Treatment
- OTHER Interview (Participant)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2024-10-01 |
| Est. Completion | 2026-11-30 |
| Phase | NA |
What the registry record for NCT07556367 still lists
NCT07556367 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 43 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 5 interventions - of which Surveys is the first listed.
NCT07556367 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07556367 about?
NCT07556367 is a clinical study titled "Post-Radiation Oral Health in Underserved Head and Neck Cancer Patients". This is a pilot study evaluates the feasibility and outcomes of providing fluoride varnish treatment during routine cancer surveillance visits for post-radiation head and neck cancer patients with limited access to dental care.
What is the current status of trial NCT07556367?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 43 participants. The study started on 2024-10-01. Estimated completion is 2026-11-30.
What interventions are being tested in trial NCT07556367?
The interventions under investigation include: Surveys (OTHER), Saliva Collection (PROCEDURE), Intra-oral photographs (PROCEDURE), Fluoride Varnish Treatment (DEVICE), Interview (Participant) (OTHER).
Who is sponsoring clinical trial NCT07556367?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07556367's enrollment target sits among peer trials
43 1435th of 2000 higher than 565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03726359 · 43 participants · Phase 1
Phase I Study of Fractionated Stereotactic Radiation Therapy
- NCT03850418 · 43 participants · Phase 2
Azacitidine and Chimerism in MDS or AML Patients After Allogeneic Stem Cell Transplant
- NCT04144023 · 43 participants · Phase 1
A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ
- NCT04176718 · 43 participants · Phase 2
Daratumumab, Carfilzomib, Pomalidomide, Dexamethasone In MM
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI